Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 11/2008

01-09-2008 | Letter to the Editor

The single nucleotide polymorphisms of matrix metalloproteinase-1 in patients with systemic sclerosis

Authors: Chung-II Joung, Young-In Na, Eun-Soon Shin, Yoon-Kyoung Sung, Dae-Hyun Yoo, Jae-Bum Jun

Published in: Rheumatology International | Issue 11/2008

Login to get access

Excerpt

Systemic sclerosis (SSc) is a connective tissue disease characterized by endothelial cell damage and activation, excessive accumulation of extracellular matrix (ECM), and fibrosis of the skin and internal organs. The regulation of production and breakdown of ECM is a central event in some physiologic (such as wound healing) and pathological conditions (SSc) [1]. …
Literature
1.
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
2.
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA (1993) Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197–250PubMed
3.
Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321–5325PubMed
4.
Johnson RW, Reveille JD, McNearney T, Fischbach M, Friedman AW, Ahn C, Arnett FC, Tan FK (2001) Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinase-1 promoter with systemic sclerosis (scleroderma). Genes Immun 2:273–275PubMedCrossRef
5.
Masi AT, Rodman GP, Medsger TA (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590CrossRef
6.
Joung CI, Jun JB, Chung WT, Song GG, Choe JY, Chang HK, Yoo DH (2006) Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea. Scand J Rheumatol 35:39–43PubMedCrossRef
7.
Ju W, Kang S, Kim JW, Park NH, Song YS, Kang SB, Lee HP (2005) Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean women. Cancer Lett 217:191–196PubMedCrossRef
8.
Iannone F, Matucci-Cerinic M, Falappone PC, Guiducci S, Cinelli M, Distler O, Lapadula G (2005) Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study. J Rheumatol 32:1893–1898PubMed
Metadata
Title
The single nucleotide polymorphisms of matrix metalloproteinase-1 in patients with systemic sclerosis
Authors
Chung-II Joung
Young-In Na
Eun-Soon Shin
Yoon-Kyoung Sung
Dae-Hyun Yoo
Jae-Bum Jun
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0628-2

Other articles of this Issue 11/2008

Rheumatology International 11/2008 Go to the issue

Letter to the Editor

Systemic lupus erythematosus, celiac disease and antiphospholipid antibody syndrome: a rare association

Case Report

A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab

Original Article

Two-year outcomes in primary THA in obese male veterans administration medical center patients

Original Article

Prevalence and clinical features of arthralgia/arthritis in healthy pregnant women

Original Article

Carotid artery intima–media thickness, heat shock proteins and oxidized LDL autoantibodies in systemic necrotizing vasculitis

Original Article

Association between ‘interleukin’ 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits